FindTrial
Sign In

Retinal function changes following laser treatment in Diabetics

Electroretinogram Changes following Multispot Laser in Proliferative Diabetic Retinopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/029156
Enrollment
50
Registered
2020-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H350- Background retinopathy and retinalvascular changes

Interventions

Control Intervention1: NIL: NIL

Sponsors

Dr Rohit Kumar Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients between 18 to 70 years of age. 2) Patients diagnosed with type I or type II diabetes mellitus 3) Patient with clear media 4) Patients with history of PDR confirmed by fluorescein angiography.

Exclusion criteria

Exclusion criteria: 1) Prior history of intravitreal injections 2) Prior history of retinal lasers 3) Significant media opacity 4) Prior history of retinal detachment 5) Prior history of vitrectomy 6) Centre involving diabetic macular edema (that may require imminent treatment) 7) Ocular abnormality that might impact ERG measurements (including more than 3 diopters of myopia)

Design outcomes

Primary

MeasureTime frame
To quantify the amount of loss of retinal function due to multispot laser in terms of full field ERG changes in a wave and b wave in rods and cone response.Timepoint: 13-09-2020 to 14-06-2020—

Secondary

MeasureTime frame
To evaluate the effect of multispot laser on best corrected visual acuity (BCVA) in patients having PDR.Timepoint: 13-09-2020 to 14-06-2020—

Countries

India

Contacts

Public ContactDr Rohit Kumar Gupta

SHRI KANCHI KAMAKOTI MEDICAL TRUST(SANKARA EYE HOSPITAL)

drprabhushanker@gmail.com9443186568

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026